These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 32297330)
1. Reactive lymphocytes in patients with COVID-19. Chong VCL; Lim KGE; Fan BE; Chan SSW; Ong KH; Kuperan P Br J Haematol; 2020 Jun; 189(5):844. PubMed ID: 32297330 [No Abstract] [Full Text] [Related]
2. SARS-CoV-2: a new aetiology for atypical lymphocytes. Gérard D; Henry S; Thomas B Br J Haematol; 2020 Jun; 189(5):845. PubMed ID: 32311762 [No Abstract] [Full Text] [Related]
3. Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome. Lee WS; Margolskee E Blood; 2020 Aug; 136(7):914. PubMed ID: 32790856 [No Abstract] [Full Text] [Related]
4. Atypical lymphocytes in peripheral blood of patients with COVID-19. Weinberg SE; Behdad A; Ji P Br J Haematol; 2020 Jul; 190(1):36-39. PubMed ID: 32420613 [No Abstract] [Full Text] [Related]
5. HMGB1: A Possible Crucial Therapeutic Target for COVID-19? Street ME Horm Res Paediatr; 2020; 93(2):73-75. PubMed ID: 32375153 [No Abstract] [Full Text] [Related]
6. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients. Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639 [TBL] [Abstract][Full Text] [Related]
7. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date. Hanley B; Roufosse CA; Osborn M; Naresh KN Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628 [No Abstract] [Full Text] [Related]
8. A NET-thrombosis axis in COVID-19. Hidalgo A Blood; 2020 Sep; 136(10):1118-1119. PubMed ID: 32882018 [No Abstract] [Full Text] [Related]
9. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 as a cause of immune thrombocytopenia. Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664 [No Abstract] [Full Text] [Related]
14. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments. Ledford H Nature; 2020 Apr; 580(7803):311-312. PubMed ID: 32273618 [No Abstract] [Full Text] [Related]
15. Early Insights into Immune Responses during COVID-19. St John AL; Rathore APS J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated adaptive immune response contributes to severe COVID-19. Yu K; He J; Wu Y; Xie B; Liu X; Wei B; Zhou H; Lin B; Zuo Z; Wen W; Xu W; Zou B; Wei L; Huang X; Zhou P Cell Res; 2020 Sep; 30(9):814-816. PubMed ID: 32759967 [No Abstract] [Full Text] [Related]